Consensus Guidelines on Chronic Spontaneous Urticaria
expert roundtables By Thomas B. Casale, MD; Allen P. Kaplan, MD; Giselle S. Mosnaim, MD, MS
Considerations Regarding Recently FDA-Approved Agents for Chronic Spontaneous Urticaria
expert roundtables By Thomas B. Casale, MD; Allen P. Kaplan, MD; Giselle S. Mosnaim, MD, MS
Latest In Conference Reporter
Advanced Imaging– and Biomarker-Guided Treatment Personalization for Metastatic Prostate Cancer
conference reporter
By Amar U. Kishan, MD
Extending Overall Survival in HR+/HER2- Advanced Breast Cancer
conference reporter
By Susan Dent, MD; Matthew P. Goetz, MD; Joseph A. Sparano, MD, FACP, FASCO
Multigene Assays and the Management of HR+/HER2- Early-Stage Breast Cancer
conference reporter
By Melinda L. Telli, MD, FASCO
Managing Endocrine Therapy–Related Side Effects and Adherence in HR+/HER2- Early-Stage Breast Cancer
conference reporter
By Virginia Kaklamani, MD, DSc; Ian Krop, MD, PhD; Melinda L. Telli, MD, FASCO
Advertisement
Advertisement